JP2015037545A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015037545A5 JP2015037545A5 JP2014156280A JP2014156280A JP2015037545A5 JP 2015037545 A5 JP2015037545 A5 JP 2015037545A5 JP 2014156280 A JP2014156280 A JP 2014156280A JP 2014156280 A JP2014156280 A JP 2014156280A JP 2015037545 A5 JP2015037545 A5 JP 2015037545A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence
- protein
- composition
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 19
- 239000000203 mixture Substances 0.000 claims 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims 7
- 108090000623 proteins and genes Proteins 0.000 claims 7
- 102000004169 proteins and genes Human genes 0.000 claims 7
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 4
- 150000001413 amino acids Chemical class 0.000 claims 3
- 125000004122 cyclic group Chemical group 0.000 claims 3
- 230000001085 cytostatic effect Effects 0.000 claims 3
- 231100000433 cytotoxic Toxicity 0.000 claims 3
- 230000001472 cytotoxic effect Effects 0.000 claims 3
- 241000233866 Fungi Species 0.000 claims 2
- 230000032770 biofilm formation Effects 0.000 claims 2
- 239000012530 fluid Substances 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- 241000203069 Archaea Species 0.000 claims 1
- 241000894006 Bacteria Species 0.000 claims 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims 1
- 238000004220 aggregation Methods 0.000 claims 1
- 230000002776 aggregation Effects 0.000 claims 1
- 239000011449 brick Substances 0.000 claims 1
- 239000004567 concrete Substances 0.000 claims 1
- 239000004744 fabric Substances 0.000 claims 1
- 239000000835 fiber Substances 0.000 claims 1
- 239000010408 film Substances 0.000 claims 1
- 239000006260 foam Substances 0.000 claims 1
- 238000004108 freeze drying Methods 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 239000011521 glass Substances 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 239000003595 mist Substances 0.000 claims 1
- 239000003973 paint Substances 0.000 claims 1
- 239000004033 plastic Substances 0.000 claims 1
- 238000001223 reverse osmosis Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13667308P | 2008-09-24 | 2008-09-24 | |
| US61/136,673 | 2008-09-24 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011527422A Division JP5676451B2 (ja) | 2008-09-24 | 2009-09-23 | ペプチド |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015037545A JP2015037545A (ja) | 2015-02-26 |
| JP2015037545A5 true JP2015037545A5 (enExample) | 2015-04-09 |
| JP5750703B2 JP5750703B2 (ja) | 2015-07-22 |
Family
ID=41698391
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011527422A Active JP5676451B2 (ja) | 2008-09-24 | 2009-09-23 | ペプチド |
| JP2014156280A Active JP5750703B2 (ja) | 2008-09-24 | 2014-07-31 | 細胞接着を予防するペプチド及び組成物、並びにこれを使用する方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011527422A Active JP5676451B2 (ja) | 2008-09-24 | 2009-09-23 | ペプチド |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US9029318B2 (enExample) |
| EP (3) | EP3670524A1 (enExample) |
| JP (2) | JP5676451B2 (enExample) |
| KR (2) | KR101594202B1 (enExample) |
| CN (2) | CN102171239B (enExample) |
| AU (1) | AU2009295575B2 (enExample) |
| CA (1) | CA2737682C (enExample) |
| ES (2) | ES2753900T3 (enExample) |
| HK (1) | HK1213903A1 (enExample) |
| IL (1) | IL211930A (enExample) |
| SG (2) | SG10201504623VA (enExample) |
| WO (1) | WO2010035107A2 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2463181B (en) | 2007-05-14 | 2013-03-27 | Univ New York State Res Found | Induction of a physiological dispersion response in bacterial cells in a biofilm |
| KR101594202B1 (ko) | 2008-09-24 | 2016-02-15 | 텔 하쇼머 메디컬 리서치 인프라스트럭쳐 앤드 서비시스 리미티드． | 세포 유착 방지를 위한 펩티드와 조성물 및 그것의 사용 방법 |
| ES2528133T3 (es) * | 2008-12-29 | 2015-02-04 | Tel Hashomer Medical Research, Infrastructure And Services Ltd. | Péptidos y composiciones para prevención de la adhesión celular, y métodos para utilizar los mismos |
| US11174299B2 (en) | 2008-12-29 | 2021-11-16 | Dispersebio Ltd. | Peptides and compositions for prevention of cell adhesion and methods of using same |
| KR20140058446A (ko) * | 2011-05-31 | 2014-05-14 | 허치슨 바이오필름 메디컬 솔루션스 리미티드 | 세포 응집물의 분산 및 분리 |
| AU2012346594B2 (en) | 2011-11-30 | 2017-12-21 | Agency For Science, Technology And Research | GM1 ganglioside to Annexin V microparticle polypeptide ratio for biological monitoring |
| AU2014343371B2 (en) * | 2013-10-31 | 2019-03-14 | Hutchison Biofilm Medical Solutions Limited | Use of peptides in antibiotic resistance |
| JP6443235B2 (ja) * | 2015-06-15 | 2018-12-26 | 三菱ケミカル株式会社 | 細胞外多糖類の検出を使用した汚泥の脱水方法 |
| KR101819190B1 (ko) * | 2015-10-14 | 2018-01-16 | 주식회사 큐얼스 | 미세조류 파괴용 조성물 |
| US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
| TN2021000088A1 (en) * | 2018-11-01 | 2023-01-05 | Biofouling Tech Inc | Durable biofouling protection |
| EP3699185A1 (en) * | 2019-02-20 | 2020-08-26 | Université de Rennes 1 | Peptides for preventing biofilm formation |
| KR102277536B1 (ko) | 2019-04-25 | 2021-07-15 | 동국대학교 산학협력단 | 생물오손 방지를 위한 체내 삽입형 의료기기 및 체내 삽입형 의료기기의 표면에 생물오손 방지막의 형성방법 |
| EP3952973B1 (en) | 2019-06-13 | 2023-06-07 | Hollister Incorporated | Reusable urinary catheter products |
| AU2020304005B2 (en) | 2019-06-25 | 2025-12-04 | Hollister Incorporated | Reusable urinary catheter products |
| KR102520633B1 (ko) | 2021-02-17 | 2023-04-11 | 동의대학교 산학협력단 | 흡수성이 향상된 치과용 멤브레인 필터 및 그 제조방법 |
| GB202305524D0 (en) * | 2023-04-14 | 2023-05-31 | Oxford Nanopore Tech Plc | Novel pore monomers and pores |
| EP4464714A1 (en) * | 2023-05-19 | 2024-11-20 | Karlsruher Institut für Technologie | Screening method for cell-repelling peptides |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154600B (nl) | 1971-02-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen. |
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| NL154599B (nl) | 1970-12-28 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking. |
| US3901654A (en) | 1971-06-21 | 1975-08-26 | Biological Developments | Receptor assays of biologically active compounds employing biologically specific receptors |
| US3853987A (en) | 1971-09-01 | 1974-12-10 | W Dreyer | Immunological reagent and radioimmuno assay |
| US3867517A (en) | 1971-12-21 | 1975-02-18 | Abbott Lab | Direct radioimmunoassay for antigens and their antibodies |
| NL171930C (nl) | 1972-05-11 | 1983-06-01 | Akzo Nv | Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen. |
| US3850578A (en) | 1973-03-12 | 1974-11-26 | H Mcconnell | Process for assaying for biologically active molecules |
| US3935074A (en) | 1973-12-17 | 1976-01-27 | Syva Company | Antibody steric hindrance immunoassay with two antibodies |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4034074A (en) | 1974-09-19 | 1977-07-05 | The Board Of Trustees Of Leland Stanford Junior University | Universal reagent 2-site immunoradiometric assay using labelled anti (IgG) |
| US3984533A (en) | 1975-11-13 | 1976-10-05 | General Electric Company | Electrophoretic method of detecting antigen-antibody reaction |
| US4098876A (en) | 1976-10-26 | 1978-07-04 | Corning Glass Works | Reverse sandwich immunoassay |
| US4286988A (en) | 1980-06-30 | 1981-09-01 | The United States Of America As Represented By The Secretary Of The Navy | Copper base antifouling paints with pH control |
| US4879219A (en) | 1980-09-19 | 1989-11-07 | General Hospital Corporation | Immunoassay utilizing monoclonal high affinity IgM antibodies |
| US4678512A (en) | 1982-02-12 | 1987-07-07 | Grams Ralph R | Marine coating compositions and method |
| US5011771A (en) | 1984-04-12 | 1991-04-30 | The General Hospital Corporation | Multiepitopic immunometric assay |
| US4666828A (en) | 1984-08-15 | 1987-05-19 | The General Hospital Corporation | Test for Huntington's disease |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4801531A (en) | 1985-04-17 | 1989-01-31 | Biotechnology Research Partners, Ltd. | Apo AI/CIII genomic polymorphisms predictive of atherosclerosis |
| GB8511144D0 (en) | 1985-05-02 | 1985-06-12 | Int Paint Plc | Marine anti-fouling paint |
| JPH07764Y2 (ja) | 1987-05-19 | 1995-01-11 | 日産自動車株式会社 | 自動変速機のロツクアツプ制御装置 |
| US4865909A (en) | 1987-10-21 | 1989-09-12 | W. L. Gore & Associates, Inc. | Microporous anti-fouling marine coating |
| US5272057A (en) | 1988-10-14 | 1993-12-21 | Georgetown University | Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase |
| US5192659A (en) | 1989-08-25 | 1993-03-09 | Genetype Ag | Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
| US5143545A (en) | 1991-09-20 | 1992-09-01 | The United States Of America As Represented By The Secretary Of The Navy | Antifouling marine coatings |
| US5281521A (en) | 1992-07-20 | 1994-01-25 | The Trustees Of The University Of Pennsylvania | Modified avidin-biotin technique |
| WO1995016000A1 (en) | 1993-12-09 | 1995-06-15 | The Research Foundation Of State University Of New York | Aquatic antifouling compositions and methods |
| AUPQ002399A0 (en) * | 1999-04-28 | 1999-05-20 | Australian National University, The | Model membrane systems |
| US7834146B2 (en) | 2000-05-08 | 2010-11-16 | Monsanto Technology Llc | Recombinant polypeptides associated with plants |
| US7556807B2 (en) | 2001-02-20 | 2009-07-07 | Kane Biotech, Inc. | Signal peptides, nucleic acid molecules and methods for treatment of caries |
| US7189351B2 (en) * | 2001-10-25 | 2007-03-13 | Spherix Incorporated | D-tagatose as an anti-biofilm agent |
| WO2003050708A1 (en) | 2001-12-07 | 2003-06-19 | Vitesse Semiconductor Company | A method and system for transporting information via the xgmii or fiber channel standard |
| GB0200689D0 (en) * | 2002-01-10 | 2002-02-27 | Univ Newcastle | Fusion proteins |
| CN1162541C (zh) * | 2002-09-03 | 2004-08-18 | 中山大学 | 一种海葵细胞毒素基因、其编码的蛋白及应用 |
| US7306923B2 (en) * | 2004-06-14 | 2007-12-11 | Galapagos N.V. | Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases |
| DE602005020320D1 (de) | 2004-06-16 | 2010-05-12 | Affinergy Inc | Grenzflächenbiomaterialien zur förderung der anhaftung von zielanalyten |
| WO2006006172A2 (en) | 2004-07-15 | 2006-01-19 | Ramot At Tel Aviv University Ltd. | Use of anti-amyloid agents for treating and typing pathogen infections |
| GB0502046D0 (en) * | 2005-02-01 | 2005-03-09 | Sinclair Pharmaceuticals Ltd | Method |
| US7976851B2 (en) | 2005-07-22 | 2011-07-12 | The Regents Of The University Of Colorado, A Body Corporate | Non-toxic biofilm inhibitor |
| US8048443B2 (en) * | 2005-12-16 | 2011-11-01 | Cerapedics, Inc. | Pliable medical device and method of use |
| US20070293435A1 (en) | 2006-06-16 | 2007-12-20 | Naomi Balaban | Identification and Use of Non-Peptide Analogs of RNAIII-Inhibiting Peptide for the Treatment of Staphylococcal Infections |
| JP2010521188A (ja) * | 2007-03-22 | 2010-06-24 | ディーエスエム アイピー アセッツ ビー．ブイ． | 新規リシルオキシダーゼ |
| US20080241281A1 (en) | 2007-03-29 | 2008-10-02 | Texas Tech University System | Compositions & methods for activation and inhibition of Staphylococcus aureus biofilm development |
| US9737571B2 (en) | 2007-09-20 | 2017-08-22 | Tel Hashomer Medical Research Infrastructure And Services Ltd. | Compositions of aquatic origin for prevention of cell adhesion and methods of using same |
| US8551555B2 (en) * | 2007-12-26 | 2013-10-08 | Intel Corporation | Biocompatible coatings for medical devices |
| KR101594202B1 (ko) * | 2008-09-24 | 2016-02-15 | 텔 하쇼머 메디컬 리서치 인프라스트럭쳐 앤드 서비시스 리미티드． | 세포 유착 방지를 위한 펩티드와 조성물 및 그것의 사용 방법 |
| ES2528133T3 (es) | 2008-12-29 | 2015-02-04 | Tel Hashomer Medical Research, Infrastructure And Services Ltd. | Péptidos y composiciones para prevención de la adhesión celular, y métodos para utilizar los mismos |
| EP3168504B1 (en) | 2014-07-09 | 2020-02-19 | Nissan Motor Co., Ltd. | Lock-up-clutch control device |
-
2009
- 2009-09-23 KR KR1020117008716A patent/KR101594202B1/ko active Active
- 2009-09-23 SG SG10201504623VA patent/SG10201504623VA/en unknown
- 2009-09-23 US US13/120,049 patent/US9029318B2/en active Active
- 2009-09-23 EP EP19184917.3A patent/EP3670524A1/en not_active Withdrawn
- 2009-09-23 AU AU2009295575A patent/AU2009295575B2/en active Active
- 2009-09-23 CA CA2737682A patent/CA2737682C/en active Active
- 2009-09-23 CN CN200980138283.3A patent/CN102171239B/zh active Active
- 2009-09-23 EP EP09740951.0A patent/EP2344521B1/en active Active
- 2009-09-23 SG SG10202000552YA patent/SG10202000552YA/en unknown
- 2009-09-23 KR KR1020157032926A patent/KR101788284B1/ko active Active
- 2009-09-23 ES ES09740951T patent/ES2753900T3/es active Active
- 2009-09-23 EP EP14153264.8A patent/EP2789626B1/en active Active
- 2009-09-23 CN CN201510209329.3A patent/CN104892728A/zh active Pending
- 2009-09-23 ES ES14153264.8T patent/ES2690348T3/es active Active
- 2009-09-23 JP JP2011527422A patent/JP5676451B2/ja active Active
- 2009-09-23 WO PCT/IB2009/006926 patent/WO2010035107A2/en not_active Ceased
-
2011
- 2011-03-24 IL IL211930A patent/IL211930A/en active IP Right Grant
- 2011-10-18 HK HK15112562.6A patent/HK1213903A1/zh unknown
-
2014
- 2014-07-31 JP JP2014156280A patent/JP5750703B2/ja active Active
-
2015
- 2015-05-08 US US14/708,014 patent/US9777050B2/en active Active
-
2017
- 2017-09-29 US US15/721,404 patent/US11001612B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015037545A5 (enExample) | ||
| JP2016533322A5 (enExample) | ||
| JP2018520654A5 (enExample) | ||
| WO2016037154A8 (en) | Recombinant hiv-1 envelope proteins and their use | |
| JP2018532705A5 (enExample) | ||
| JP2013539361A5 (enExample) | ||
| JP2011097941A5 (enExample) | ||
| WO2016004906A3 (zh) | 一种肿瘤血管阻断剂多肽、基因、表达载体及其应用 | |
| JP2013177388A5 (enExample) | ||
| AR083354A1 (es) | Polipeptidos variantes cbh i (celobiohidrolasas i) con reducida inhibicion de producto | |
| JP2015505473A5 (ja) | 細胞培養のための合成接着培地 | |
| JP2017516475A5 (enExample) | ||
| WO2016140259A3 (ja) | ポリマーおよびその架橋体 | |
| EP4095152A3 (en) | Engineered ribosomal promoters for protein production in microorganisms | |
| WO2017176807A3 (en) | Compositions for inhibiting formation of and/or disrupting bacterial biofilms and methods of use therefor | |
| US20180002535A1 (en) | A method for treating a surface and an article comprising a layer of microbial structures | |
| JP2013531491A5 (enExample) | ||
| RU2017142878A (ru) | Микроорганизм рода Escherichia, обладающий продуктивностью по L-триптофану, и способ получения L-триптофана с его использованием | |
| JP2013504519A5 (enExample) | ||
| CA3010564A1 (en) | An antibacterial composition and a method of treating staphylococcal infections with the antibacterial composition | |
| HRP20201945T1 (hr) | Postupak proizvodnje gonadotropina | |
| RU2017141773A (ru) | Микроорганизм рода Escherichia, продуцирующий L-триптофан, и способ получения L-триптофана с его использованием | |
| EP2374882A4 (en) | NOVEL AMINO ACID DEHYDROGENASE, AND PROCESS FOR PRODUCING L-AMINO ACID, 2-OXO ACID, OR D-AMINO ACID | |
| WO2015134928A3 (en) | Point of care assays to detect the status of tuberculosis infection | |
| AR107725A1 (es) | Composiciones, organismos, sistemas y métodos de cítricos resistentes a patógenos |